US 10076505
Inhalation formulations of Treprostinil
granted A61KA61K31/19A61K31/191
Quick answer
US patent 10076505 (Inhalation formulations of Treprostinil) held by United Therapeutics Corporation expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/19, A61K31/191, A61K31/192, A61K31/201